These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33391260)

  • 1. Anti-CD2 Antibody-Coated Nanoparticles Containing IL-2 Induce NK Cells That Protect Lupus Mice
    Horwitz DA; Liu A; Bickerton S; Castaldo G; Matarese G; Fahmy TM; La Cava A
    Front Immunol; 2020; 11():583338. PubMed ID: 33391260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of Murine Lupus by CD4+ and CD8+ Treg Cells Induced by T Cell-Targeted Nanoparticles Loaded With Interleukin-2 and Transforming Growth Factor β.
    Horwitz DA; Bickerton S; Koss M; Fahmy TM; La Cava A
    Arthritis Rheumatol; 2019 Apr; 71(4):632-640. PubMed ID: 30407752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cells inhibit the development of autoantibody production in (C57BL/6 x DBA/2) F1 hybrid mice injected with DBA/2 spleen cells.
    Harada M; Lin T; Kurosawa S; Maeda T; Umesue M; Itoh O; Matsuzaki G; Nomoto K
    Cell Immunol; 1995 Mar; 161(1):42-9. PubMed ID: 7867084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome.
    Zheng SG; Wang JH; Koss MN; Quismorio F; Gray JD; Horwitz DA
    J Immunol; 2004 Feb; 172(3):1531-9. PubMed ID: 14734731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic and Therapeutic Effects of Interleukin-2 (IL-2)/Anti-IL-2 Complexes in Systemic Lupus Erythematosus-Like Chronic Graft-Versus-Host Disease.
    Heiler S; Lötscher J; Kreuzaler M; Rolink J; Rolink A
    Front Immunol; 2018; 9():656. PubMed ID: 29670626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between CD8+ T cells in lupus-prone (NZB x NZW) F1 mice and healthy (BALB/c x NZW) F1 mice may influence autoimmunity in the lupus model.
    Karpouzas GA; La Cava A; Ebling FM; Singh RR; Hahn BH
    Eur J Immunol; 2004 Sep; 34(9):2489-99. PubMed ID: 15307181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine-mediated down-regulation of B cell activity in SLE: effects of interleukin-2 and transforming growth factor-beta.
    Ohtsuka K; Gray JD; Quismorio FP; Lee W; Horwitz DA
    Lupus; 1999; 8(2):95-102. PubMed ID: 10192502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic Differences in Donor CD4 T Cell IL-2 Production Influence Severity of Parent-into-F1 Murine Lupus by Skewing the Immune Response Either toward Help for B Cells and a Sustained Autoantibody Response or toward Help for CD8 T Cells and a Downregulatory Th1 Response.
    Soloviova K; Puliaiev M; Haas M; Dalgard CL; Schaefer BC; Via CS
    J Immunol; 2015 Oct; 195(7):2985-3000. PubMed ID: 26320249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus.
    Ohtsuka K; Gray JD; Stimmler MM; Toro B; Horwitz DA
    J Immunol; 1998 Mar; 160(5):2539-45. PubMed ID: 9498800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-beta: contrasting effects of anti-CD2 and anti-CD3.
    Gray JD; Hirokawa M; Ohtsuka K; Horwitz DA
    J Immunol; 1998 Mar; 160(5):2248-54. PubMed ID: 9498764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
    Van Rappard-Van Der Veen FM; Radaszkiewicz T; Terraneo L; Gleichmann E
    J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation.
    Hao J; Campagnolo D; Liu R; Piao W; Shi S; Hu B; Xiang R; Zhou Q; Vollmer T; Van Kaer L; La Cava A; Shi FD
    Ann Neurol; 2011 Apr; 69(4):721-34. PubMed ID: 21425186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-2-activated CD8+CD44high cells express both adaptive and innate immune system receptors and demonstrate specificity for syngeneic tumor cells.
    Dhanji S; Teh HS
    J Immunol; 2003 Oct; 171(7):3442-50. PubMed ID: 14500639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of programmed death-1 in young (New Zealand black x New Zealand white)F1 mice promotes the activity of suppressive CD8+ T cells that protect from lupus-like disease.
    Wong M; La Cava A; Singh RP; Hahn BH
    J Immunol; 2010 Dec; 185(11):6563-71. PubMed ID: 21041733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The parent-into-F1 murine model in the study of lupus-like autoimmunity and CD8 cytotoxic T lymphocyte function.
    Soloviova K; Puliaiev M; Foster A; Via CS
    Methods Mol Biol; 2012; 900():253-70. PubMed ID: 22933073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential of human regulatory T cells generated ex vivo as a treatment for lupus and other chronic inflammatory diseases.
    Horwitz DA; Gray JD; Zheng SG
    Arthritis Res; 2002; 4(4):241-6. PubMed ID: 12106494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of programmed death-1 in young (New Zealand Black x New Zealand White)F1 mice promotes the suppressive capacity of CD4+ regulatory T cells protecting from lupus-like disease.
    Wong M; La Cava A; Hahn BH
    J Immunol; 2013 Jun; 190(11):5402-10. PubMed ID: 23636058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasculitis in the Palmerston North mouse model of lupus: phenotype and cytokine production profile of infiltrating cells.
    Luzina IG; Knitzer RH; Atamas SP; Gause WC; Papadimitriou JC; Sztein MB; Storrer CE; Handwerger BS
    Arthritis Rheum; 1999 Mar; 42(3):561-8. PubMed ID: 10088780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory effects of cytokine-induced expansion of cytotoxic lymphocytes in a mouse model of lupus-like disease.
    Reighard SD; Krishnamurthy D; Cevik H; Ochayon DE; Ali A; Seelamneni H; Brunner HI; Waggoner SN
    Cytotherapy; 2021 Jan; 23(1):37-45. PubMed ID: 33092988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated allogeneic NK cells as suppressors of alloreactive responses.
    Hu B; He Y; Wu Y; Bao G; Liu H; Welniak LA; Murphy WJ
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):772-81. PubMed ID: 20197103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.